October 25,2010
Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
Recent News
- Wyden Hails Senate Passage of Legislation to Reauthorize & Modernize Title IV-B to Better Support Children and Families in America
- Wyden, Durbin, Brown Investigate Trump Advisor Boris Epshteyn’s Cash for Cabinet Appointment Scheme
- Wyden Urges GAO to Investigate the Deceptive Marketing Schemes of Youth Residential Treatment Facilities
- Wyden Investigation Highlights Dangers of Post-Dobbs Emergency Medical Care for Pregnant Women
- Wyden, Ossoff, Warnock Seek Watchdog Investigation into Waste and Mismanagement in Georgia Pathways Program